Clinical Trials & Medical Discoveries Headlines from PR Newswire

< Go Back

Birch Pollen Allergy Global Clinical Trials Review, H2, 2014
Microscopic Polyangiitis (MPA) Global Clinical Trials Review, H2, 2014
Ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2014
Ischemia Reperfusion Injury Global Clinical Trials Review, H2, 2014
Cat Allergy Global Clinical Trials Review, H2, 2014
Intermittent Claudication Global Clinical Trials Review, H2, 2014
Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2014
Cedar Pollen Allergy Global Clinical Trials Review, H2, 2014
Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014
Hypertropic Cardiomyopathy Global Clinical Trials Review, H2, 2014
Hyperemia Global Clinical Trials Review, H2, 2014
Reliable Revenues Expected for Catheter Manufacturers: Urology Device Market Led by Coloplast and C. R. Bard
MedNet Solutions To Host Third Annual iMedNet User Group Meeting
UCB-sponsored Data on Cimzia® (certolizumab pegol) to be Highlighted at American College of Gastroenterology 2014 Annual Scientific Meeting
ALS ACT, The ALS Association, and the Northeast ALS Consortium Issue Request for Proposals for Phase II Clinical Development of Novel, High-Potential Treatments for ALS
BioLight to Present at the Canaccord Genuity 2014 Medical Technology and Diagnostics Forum
Adheris Health, Behavioral Insights Group Launches Next Phase Of Ethnographic Study To Help Healthcare Companies Effectively Engage With American Families
New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies
Retina Implant AG Clinical Investigator Presents Global Trial Results at the 2014 American Academy of Ophthalmology Annual Meeting Spanish Spanish
Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip
Profectus BioSciences Receives Department of the Army Funding for Studies Directed Toward the Development of a VesiculoVax™ rVSV-Vectored Vaccine for Ebola and Marburg Viruses
Profectus BioSciences Receives $8.6 Million HHS Contract to Accelerate Ebola Vaccine into Human Clinical Studies
Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes
Report: Radical New IVD Test Approaches Key To Growth
Expanding Orthopedics Inc. Granted a New US patent - Adding to its Extensive IP Portfolio of Expandable Bone Devices
Nuvo Research® Completes WF10™ U.S. Market Study for Treatment of Refractory Allergies
Recent Clinical Study Data Confirms Efficacy of Stretta Therapy - Spurs Additional Insurance Coverage and Financing Round
AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results
New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease
New Randomized Study Shows 3.15% Chlorhexidine Gluconate/70% Isopropyl Alcohol Solution Most Effective for Disinfecting Needleless Access Sites at 5 Second Scrub Time
MabVax Therapeutics Nominates The Fully Human Antibody HuMab 5B1 As The Company's Lead Clinical Development Candidate
TWi Biotechnology Receives Orphan Drug Designation for its Lead Drug Candidate AC-201 in United States
Automated EEG Biofeedback Proven Effective in Addiction Treatment
National Multi-Center Clinical Trial of Non-Surgical Breast Cancer Treatment Enrolls First Patients
Boehringer Ingelheim initiates global Phase III study investigating nintedanib in patients with colorectal cancer
VNSNY to Present Patient Outcome Results from AMC Health Telehealth Program at WEDI Fall Conference
First Patient Successfully Implanted in Safety/Efficacy Study of Beta-O2's ßAir Bio-Artificial Pancreas for Type 1 Diabetes
Omeros Provides Update on PDE10 Inhibitor Program
Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bacteria
Maxwell Biotech Portfolio Company Hepatera Announces Proof-of-Concept Clinical Results with Myrcludex B, a Novel Entry Inhibitor for Treatment of Chronic Hepatitis B and Delta
Auxogyn Announces Oral Presentations on the Eeva™ Test at the Annual Meeting of the American Society for Reproductive Medicine
Neurocrine Announces Initiation Of Phase III Study For VMAT2 Inhibitor NBI-98854
Cardiothoracic and Vascular Surgeons, in Collaboration with Heart Hospital of Austin, First in Texas to Implant Solo Smart™ Aortic Pericardial Heart Valve
Cypher Genomics Identifies and Verifies Genetic Cause of Rare Disease, Epileptic Encephalopathy
New Treatment Reported for a Potentially Fatal Lymphatic Complication in Children with Heart Disease
Global Alliance for Genomics and Health Members Meet to Advance Genomic Data Sharing
Milo Biotechnology's Follistatin Gene Therapy Increases Function in Becker Muscular Dystrophy Patients
RegeneRx Allowed to Proceed with Phase 3 Using RGN-259 Eye Drops for the Treatment of Neurotrophic Keratopathy
Autonomic Dysfunction in Parkinson's Disease With and Without Deep Brain Stimulation
Novel i-FACTOR™ Biologic Bone Graft Shown to Improve Clinical Outcomes in ALIF Procedures

< Prev Next >
PR Newswire - United Business Media